Timolol

Sold as Glaucosan, Glaucobex, Timoptol-xe, Timpotol-xe, Oftan timolol sdu, Oftan timolol, Glaucare, Occumol (eye ), Oglasan xe, Timoptol, Timolol maleate lennon

S3Read from the PI-PIL document and verified

C₁₃H₂₄N₄O₃S316.42 g/mol

(2S)-1-(tert-Butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol

Drag to rotate. Structure from PubChem CID 33624.

Loading Wikipedia summary

Registration

Applicants: 8
Registrations: 17
Schedule source: SAHPRA documentation

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Hexal Pharma (SA) (Pty) LtdCancelled	Glaucosan	0,1%, 0,25%	270312, 270403	Not determined	None
Ipharma (Pty) Ltd	Glaucobex	0.5 %	270313	Not determined	None
Mundipharma (Pty) Ltd2 of 4 cancelled	Timoptol-xe, Timpotol-xe, Timoptol	0,5 %, 2.5 mg/ 5.0 mg, 2.5mg / 5mg	290230, 290231, K0339, K0340	S3	PI PIL
Alliance Pharma (Pty) Ltd	Oftan timolol sdu, Oftan timolol	0,25%, 0,25 %, 0,5 %	310276, 310277, 310278, 310279	Not determined	None
Acino Pharma (Pty) Ltd	Glaucare	0,25 %, 0,5 %	360476, 360477	Not determined	None
Gulf Drug Company (Pty) Ltd	Occumol (eye )	0,25 %, 0,5 %	430136, 430137	Not determined	None
Ranbaxy Pharmaceutical (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) Ltd	Oglasan xe	0,5%	520175	S3	PI PIL
Pharmacare limited û woodmead	Timolol maleate lennon	10 mg -	W0162	Not determined	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Glaucosan 0,25%* EACH 1 ml LIQUID CONTAINS TIMOLOL MALEATE EQUIVALENT TO 2,5 mg TIMOLOL	0,25%	27031227/15.4/0312	Cancelled	Not determined	None
Glaucobex 0.5 % EACH 1,0 ml LIQUID CONTAINS TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 5,0 mg	0.5 %	27031327/15.4/0313	Registered	Not determined	None
Glaucosan 0,1% EACH 1,0 ml LIQUID CONTAINS TIMOLOL MALEATE EQUIVALENT TO 1,0 mg TIMOLOL	0,1%	27040327/15.4/0403	Cancelled	Not determined	None
Timoptol-xe 0,25 % EACH 1 ml SOLUTION CONTAINS TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 2,5 mg	2.5 mg/ 5.0 mgSterile ophthalmic gellan solution	29023029/15.4/0230Approved 11 March 2022	Cancelled	S3	PI PIL
Timpotol-xe 0,5 % EACH 1 ml SOLUTION CONTAINS TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 5,0 mg	0,5 %	29023129/15.4/0231	Registered	Not determined	None
Oftan timolol 0,25% sdu EACH 1,0 ml SOLUTION CONTAINS TIMOLOL MALEATE EQUIVALENT TO 2,5 mg TIMOLOL	0,25%	31027631/15.4/0276	Registered	Not determined	None
Oftan timolol 0,5 % sdu EACH 1 ml SOLUTION CONTAINS TIMOLOL MALEATE EQUIVALENT TO 5 mg TIMOLOL	0,5 %	31027731/15.4/0277	Registered	Not determined	None
Oftan timolol 0,25 % EACH 1 ml SOLUTION CONTAINS TIMOLOL MALEATE EQUIVALENT TO 2,5 mg TIMOLOL	0,25 %	31027831/15.4/0278	Registered	Not determined	None
Oftan timolol 0,5 % EACH 1 ml SOLUTION CONTAINS TIMOLOL MALEATE EQUIVALENT TO 5 mg TIMOLOL	0,5 %	31027931/15.4/0279	Registered	Not determined	None
Glaucare 0,25 % EACH 1,0 ml DROPS CONTAINS TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 2,5 mg	0,25 %	36047636/15.4/0476	Registered	Not determined	None
Glaucare 0,5 % EACH 1,0 ml DROPS CONTAINS TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 5,0 mg	0,5 %	36047736/15.4/0477	Registered	Not determined	None
Occumol 0,5 % (eye drop) EACH 1,0 ml DROPS CONTAINS TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 5,0 mg	0,5 %Drop)	43013643/15.4/0136	Registered	Not determined	None
Occumol 0,25 % (eye drop) EACH 1,0 ml DROPS CONTAINS TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 2,5 mg	0,25 %Drop)	43013743/15.4/0137	Registered	Not determined	None
Oglasan xe 0,5% EACH 1 ML OF SOLUTION CONTAINS: TIMOLOL (AS MALEATE) 5,0 mg	0,5%Sterile ophthalmic solution	52017552/15.4/0175Approved 4 May 2023	Registered	S3	PI PIL
Timoptol 0,25 % EACH 1 ml SOLUTION CONTAINS TIMOLOL MALEATE EQUIVALENT TO 2,5 mg TIMOLOL	2.5mg / 5mgOphthalmic solution	K0339K/15.4/339Approved 23 November 2019	Cancelled	Not determined	PI PIL
Timoptol 0,5 % EACH 1 ml SOLUTION CONTAINS TIMOLOL MALEATE EQUIVALENT TO 5 mg TIMOLOL	2.5mg / 5mgOphthalmic solution	K0340K/15.4/340Approved 23 November 2019	Registered	S3	PI PIL
Timolol maleate 10 MG - lennon EACH TABLET CONTAINS TIMOLOL MALEATE 10 mg	10 mg -	W0162W/5.2/162	Registered	Not determined	None

Regulatory status

Where S3 sits on the scale

S0S1S2S3S4S5S6S7S8

Needs a doctor's prescription, dispensed by a pharmacist.

Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S3, read from the product's PI-PIL leaflet.

The Consolidated Schedules list this ingredient up to S4; the leaflet's S3 applies to this product.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Timolol maleate equivalent to timolol

S4: Bimatoprost
Consolidated Schedules 06 July 2026, line 5499
S4: Latanoprost
Consolidated Schedules 06 July 2026, line 6878
S4: Travoprost
Consolidated Schedules 06 July 2026, line 8272
S3: Brinzolamide
Consolidated Schedules 06 July 2026, line 3235
S3: Dorzolamide
Consolidated Schedules 06 July 2026, line 3486
S3: Timolol
Consolidated Schedules 06 July 2026, line 4325

Pharmacological class: Others. (class 15.4)

Matched through the components Bimatoprost, Dorzolamide, Latanoprost, Brinzolamide, Travoprost.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Timoptol-xe 0,25 %, Mundipharma (Pty) Ltd is scheduled S3 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsTimoptol-xe 0,25 %, Mundipharma (Pty) Ltd Patient information leaflet (PIL)For patients and carersTimoptol-xe 0,25 %, Mundipharma (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background